| Title | Therapeutic Advances in Vaccines and Immunotherapy |
| Abbreviation | Ther. Adv. Vaccines Immunother. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q2); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2); Pharmacology (medical) (Q2) |
| h-index | 17 |
| Overall Rank/Ranking | 5801 |
| SCImago Journal Rank (SJR) | 0.889 |
| Impact Score | 3.14 |
| Publisher | SAGE Publications Ltd |
| Country | United Kingdom |
| ISSN | 25151355, 25151363 |
| Best Quartile | Q2 |
| Coverage History | 2017-2025 |
Therapeutic Advances in Vaccines and Immunotherapy is a journal covering the technologies/fields/categories related to Drug Discovery (Q2); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2); Pharmacology (medical) (Q2). It is published by SAGE Publications Ltd. The overall rank of Therapeutic Advances in Vaccines and Immunotherapy is 5801. According to SCImago Journal Rank (SJR), this journal is ranked 0.889. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 17. The best quartile for this journal is Q2.
The ISSN of Therapeutic Advances in Vaccines and Immunotherapy journal is 25151355, 25151363. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Vaccines and Immunotherapy is cited by a total of 178 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Therapeutic Advances in Vaccines and Immunotherapy is 3.14, which is computed in 2025 as per its definition. Therapeutic Advances in Vaccines and Immunotherapy IF is decreased by a factor of 0.6 and approximate percentage change is -16.04% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Therapeutic Advances in Vaccines and Immunotherapy is 3.14. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3.14 |
| 2023 | 3.74 |
| 2022 | 2.80 |
| 2021 | 3.33 |
| 2020 | 4.94 |
| 2019 | 4.80 |
| 2018 | 2.50 |
| 2017 | 0.00 |
Therapeutic Advances in Vaccines and Immunotherapy has an h-index of 17. It means 17 articles of this journal have more than 17 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Therapeutic Advances in Vaccines and Immunotherapy is 25151355, 25151363. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Therapeutic Advances in Vaccines and Immunotherapy is 5801. According to SCImago Journal Rank (SJR), this journal is ranked 0.889. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.889 |
| 2023 | 0.726 |
| 2022 | 0.800 |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5801 |
| 2023 | 7160 |
| 2022 | 5982 |
| 2021 | 28206 |
| 2020 | 34877 |
| 2019 | 32622 |
| 2018 | 34081 |
| 2017 | 34854 |
Therapeutic Advances in Vaccines and Immunotherapy is published by SAGE Publications Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2017-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Therapeutic Advances in Vaccines and Immunotherapy is Ther. Adv. Vaccines Immunother.. This abbreviation ('Ther. Adv. Vaccines Immunother.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q2); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Therapeutic Advances in Vaccines and Immunotherapy latest impact IF is 3.14. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.94 (2020) and 0.00 (2017), respectively, in the last 8 years. Moreover, its average IS is 3.16 in the previous 8 years.
The Therapeutic Advances in Vaccines and Immunotherapy has an SJR (SCImago Journal Rank) of 0.889, according to the latest data. It is computed in the year 2025. In the past 8 years, this journal has recorded a range of SJR, with the highest being 0.889 in 2024 and the lowest being in 2021. Furthermore, the average SJR of the Therapeutic Advances in Vaccines and Immunotherapy over the previous 8-year period stands at 3.16.
The latest h-index of the Therapeutic Advances in Vaccines and Immunotherapy is 17.
The Therapeutic Advances in Vaccines and Immunotherapy is published by the SAGE Publications Ltd, with its country of publication being the United Kingdom.
The Therapeutic Advances in Vaccines and Immunotherapy is currently ranked 5801 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 8 years, this journal has experienced varying rankings, reaching its highest position of 5801 in 2024 and its lowest position of 34877 in 2020.
The standard ISO4 abbreviation for the Therapeutic Advances in Vaccines and Immunotherapy is Ther. Adv. Vaccines Immunother..
Therapeutic Advances in Vaccines and Immunotherapy is classified as a journal that the SAGE Publications Ltd publishes.
The Therapeutic Advances in Vaccines and Immunotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Therapeutic Advances in Vaccines and Immunotherapy is assigned the following International Standard Serial Numbers (ISSN): 25151355, 25151363.
The best quartile for the Therapeutic Advances in Vaccines and Immunotherapy is Q2 (2024).
The Therapeutic Advances in Vaccines and Immunotherapy coverage history can be summarized as follows: 2017-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Journal of Academic Ethics | journal | 8704 | Springer Netherlands | 34 | 4.04 |
| Current Sociology | journal | 5151 | SAGE Publications Ltd | 86 | 3.02 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 17452 | Taylor and Francis Ltd. | 27 | 1.17 |
| Abacus | journal | 11890 | Wiley-Blackwell Publishing Ltd | 56 | 2.95 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Socialism and Democracy | journal | 27160 | Taylor and Francis Ltd. | 19 | 0.20 |
| European Journal of Education | journal | 4974 | Wiley-Blackwell Publishing Ltd | 63 | 5.08 |
| Sex Education | journal | 6348 | Routledge | 51 | 2.49 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3.14 |
| 2023 | 3.74 |
| 2022 | 2.80 |
| 2021 | 3.33 |
| 2020 | 4.94 |
| 2019 | 4.80 |
| 2018 | 2.50 |
| 2017 | 0.00 |
